These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

942 related items for PubMed ID: 18515525

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.
    Circulation; 2010 Aug 03; 122(5):478-87. PubMed ID: 20644016
    [Abstract] [Full Text] [Related]

  • 7. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group.
    N Engl J Med; 2006 Sep 07; 355(10):992-1005. PubMed ID: 16957146
    [Abstract] [Full Text] [Related]

  • 8. Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors.
    Hirashima C, Ohkuchi A, Takahashi K, Suzuki H, Yoshida M, Ohmaru T, Eguchi K, Ariga H, Matsubara S, Suzuki M.
    Hypertens Res; 2011 Feb 07; 34(2):212-7. PubMed ID: 21048778
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Ramírez-Valenzuela KL, Chinolla-Arellano ZL, Isordia-Salas I.
    Hypertension; 2013 May 07; 61(5):1118-25. PubMed ID: 23460287
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
    Lim JH, Kim SY, Park SY, Lee MH, Yang JH, Kim MY, Chung JH, Lee SW, Ryu HM.
    Prenat Diagn; 2009 May 07; 29(5):471-6. PubMed ID: 19253312
    [Abstract] [Full Text] [Related]

  • 14. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N, Naicker T, Rajakumar A, Moodley J.
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep 07; 170(1):100-5. PubMed ID: 23806447
    [Abstract] [Full Text] [Related]

  • 15. Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption.
    Tikkanen M, Stenman UH, Nuutila M, Paavonen J, Hiilesmaa V, Ylikorkala O.
    Prenat Diagn; 2007 Dec 07; 27(12):1143-6. PubMed ID: 17960788
    [Abstract] [Full Text] [Related]

  • 16. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
    Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, Dong Z, Than NG, Yeo L, Hernandez-Andrade E, Conde-Agudelo A, Hassan SS.
    Am J Obstet Gynecol; 2013 Apr 07; 208(4):287.e1-287.e15. PubMed ID: 23333542
    [Abstract] [Full Text] [Related]

  • 17. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D, Eleftheriades M, Karampas G, Rizou M, Haliassos A, Hassiakos D, Vitoratos N.
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec 07; 171(2):225-30. PubMed ID: 24035323
    [Abstract] [Full Text] [Related]

  • 18. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
    Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M.
    Hypertens Pregnancy; 2009 Feb 07; 28(1):95-108. PubMed ID: 19165674
    [Abstract] [Full Text] [Related]

  • 19. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC, Thériault S, Massé J, Bujold E, Giguère Y.
    Clin Chem Lab Med; 2014 Aug 07; 52(8):1169-78. PubMed ID: 24535301
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.